Skip to main content
Livermore
Livermore
ZHEN

Perigon Wealth Management, LLC

SEC CIK
0001575239
Latest filing
Aug 7, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Perigon Wealth Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
8,834
Value
$4.39M
% of portfolio
0.1%
Quarters held
20
Since Q1 2021
Holdings of VRTX by Perigon Wealth Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20268,834$4.39M0.1%+2,380+36.9%AddedHolders
Q1 20266,454$2.88M0.1%+410+6.8%AddedHolders
Q4 20256,044$2.74M<0.1%−64−1.0%ReducedHolders
Q3 20256,108$2.39M<0.1%+104+1.7%AddedHolders
Q2 20256,004$2.67M0.1%+724+13.7%AddedHolders
Q1 20255,280$2.56M0.1%+337+6.8%AddedHolders
Q4 20244,943$2.06M0.1%+94+1.9%AddedHolders
Q3 20244,849$2.26M0.1%+4,849NewHolders
Q1 20240$00.0%−1,432−100.0%Sold outHolders
Q4 20231,432$582.7K<0.1%+8+0.6%AddedHolders
Q3 20231,424$495.2K<0.1%−124−8.0%ReducedHolders
Q2 20231,548$544.8K<0.1%+216+16.2%AddedHolders
Q1 20231,332$419.7K<0.1%−407−23.4%ReducedHolders
Q4 20221,739$502.2K<0.1%+147+9.2%AddedHolders
Q3 20221,592$461.0K<0.1%−1,038−39.5%ReducedHolders
Q2 20222,630$741.0K0.1%−1,011−27.8%ReducedHolders
Q1 20223,641$950.0K0.1%+526+16.9%AddedHolders
Q4 20213,115$684.0K<0.1%+444+16.6%AddedHolders
Q3 20212,671$484.0K<0.1%−469−14.9%ReducedHolders
Q2 20213,140$633.0K0.1%+996+46.5%AddedHolders
Q1 20212,144$461.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.